PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA

SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DEASON, MICHAEL E, SPROULL, STEVEN J, DEAN, WILLIAM D, CONROW, RAYMOND E, DANTANARAYANA, ANURA P
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DEASON, MICHAEL E
SPROULL, STEVEN J
DEAN, WILLIAM D
CONROW, RAYMOND E
DANTANARAYANA, ANURA P
description SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO. Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2160613TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2160613TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2160613TT33</originalsourceid><addsrcrecordid>eNrjZDAJCHINcAxydPb091NwcVXw9PPwdPJ08Q9yDQZxfRwVHIEiLkGOwY4Kzo5BTv5-ns6OPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNDMwMzQOCTE2JgYNQCfaydT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><source>esp@cenet</source><creator>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</creator><creatorcontrib>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</creatorcontrib><description>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO. Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20011116&amp;DB=EPODOC&amp;CC=ES&amp;NR=2160613T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20011116&amp;DB=EPODOC&amp;CC=ES&amp;NR=2160613T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEASON, MICHAEL E</creatorcontrib><creatorcontrib>SPROULL, STEVEN J</creatorcontrib><creatorcontrib>DEAN, WILLIAM D</creatorcontrib><creatorcontrib>CONROW, RAYMOND E</creatorcontrib><creatorcontrib>DANTANARAYANA, ANURA P</creatorcontrib><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><description>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO. Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJCHINcAxydPb091NwcVXw9PPwdPJ08Q9yDQZxfRwVHIEiLkGOwY4Kzo5BTv5-ns6OPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNDMwMzQOCTE2JgYNQCfaydT</recordid><startdate>20011116</startdate><enddate>20011116</enddate><creator>DEASON, MICHAEL E</creator><creator>SPROULL, STEVEN J</creator><creator>DEAN, WILLIAM D</creator><creator>CONROW, RAYMOND E</creator><creator>DANTANARAYANA, ANURA P</creator><scope>EVB</scope></search><sort><creationdate>20011116</creationdate><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><author>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2160613TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DEASON, MICHAEL E</creatorcontrib><creatorcontrib>SPROULL, STEVEN J</creatorcontrib><creatorcontrib>DEAN, WILLIAM D</creatorcontrib><creatorcontrib>CONROW, RAYMOND E</creatorcontrib><creatorcontrib>DANTANARAYANA, ANURA P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEASON, MICHAEL E</au><au>SPROULL, STEVEN J</au><au>DEAN, WILLIAM D</au><au>CONROW, RAYMOND E</au><au>DANTANARAYANA, ANURA P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><date>2001-11-16</date><risdate>2001</risdate><abstract>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO. Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2160613TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A23%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEASON,%20MICHAEL%20E&rft.date=2001-11-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2160613TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true